Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Cardiac rehabilitation may influence leptin and VEGF A crosstalk in patients after acute coronary syndrome

View through CrossRef
AbstractLeptin, a well-proven cardiovascular risk factor, influences vascular endothelial growth factor A (VEGF A) synthesis via hypoxia-inducible factor 1 alpha (HIF-1A), nuclear factor kappa-light-chain-enhancer of activated B cells (NfkB) and NILCO (Notch, interleukin 1 [IL1] and leptin cross-talk outcome) pathways. This study aimed to investigate the influence of cardiac rehabilitation (CR) on HIF-1A, NfkB and NILCO dependent leptin and VEGF A cross-talk in patients after acute coronary syndrome (ACS). Fifty post-ACS patients underwent a 2-week CR programme (study group S) and were compared to 50 post-ACS subjects who did not undergo CR (control group K). In group S, at baseline and at completion and in group K once, anthropometric, body composition, blood pressure and heart rate measurements were taken and blood sampling was performed. Serum levels of leptin, VEGF A, VEGF receptor 2 (VEGF R2), HIF-1A, NfkB, interleukin 1-alpha (IL1-alpha) and Notch 1 were determined. In group S, serum VEGF A levels increased while leptin, HIF-1A and VEGF R2 levels decreased and completion but not baseline serum leptin correlated positively with serum VEGF A. Also, serum completion VEGF A correlated positively with NfkB and HIF-1A in group S. Correlation analysis in group S confirmed the significant role of the NILCO pathway in the regulation of VEGF A serum levels mediated by HIF-1A and NfkB. CR may induce the predomination of the NILCO pathway interacting with HIF-1A and NfkB over leptin canonical and non-canonical signalling pathways in the leptin influence on VEGF A in post-ACS patients.Trial registration: ClinicalTrials.gov ID: NCT03935438. The CARDIO-REH randomised study.
Title: Cardiac rehabilitation may influence leptin and VEGF A crosstalk in patients after acute coronary syndrome
Description:
AbstractLeptin, a well-proven cardiovascular risk factor, influences vascular endothelial growth factor A (VEGF A) synthesis via hypoxia-inducible factor 1 alpha (HIF-1A), nuclear factor kappa-light-chain-enhancer of activated B cells (NfkB) and NILCO (Notch, interleukin 1 [IL1] and leptin cross-talk outcome) pathways.
This study aimed to investigate the influence of cardiac rehabilitation (CR) on HIF-1A, NfkB and NILCO dependent leptin and VEGF A cross-talk in patients after acute coronary syndrome (ACS).
Fifty post-ACS patients underwent a 2-week CR programme (study group S) and were compared to 50 post-ACS subjects who did not undergo CR (control group K).
In group S, at baseline and at completion and in group K once, anthropometric, body composition, blood pressure and heart rate measurements were taken and blood sampling was performed.
Serum levels of leptin, VEGF A, VEGF receptor 2 (VEGF R2), HIF-1A, NfkB, interleukin 1-alpha (IL1-alpha) and Notch 1 were determined.
In group S, serum VEGF A levels increased while leptin, HIF-1A and VEGF R2 levels decreased and completion but not baseline serum leptin correlated positively with serum VEGF A.
Also, serum completion VEGF A correlated positively with NfkB and HIF-1A in group S.
Correlation analysis in group S confirmed the significant role of the NILCO pathway in the regulation of VEGF A serum levels mediated by HIF-1A and NfkB.
CR may induce the predomination of the NILCO pathway interacting with HIF-1A and NfkB over leptin canonical and non-canonical signalling pathways in the leptin influence on VEGF A in post-ACS patients.
Trial registration: ClinicalTrials.
gov ID: NCT03935438.
The CARDIO-REH randomised study.

Related Results

Leptin–VEGF crosstalk in excess body mass and related disorders: A systematic review
Leptin–VEGF crosstalk in excess body mass and related disorders: A systematic review
SummaryBy 2030, it is expected that a billion people will have suffer from obesity. Adipose tissue synthesizes leptin, an adipokine that affects cardiovascular risk. Leptin intensi...
Regulation and Action of Leptin in Pregnant and Lactating Dairy Cows.
Regulation and Action of Leptin in Pregnant and Lactating Dairy Cows.
The original project had four specific objectives: (1) To complete the development of a radioimmunoassay for bovine leptin; (2) To characterize the leptin system in lactating dairy...
Abstract 1005: Leptin increases VEGF expression and enhances angiogenesis in human chondrosarcoma cells
Abstract 1005: Leptin increases VEGF expression and enhances angiogenesis in human chondrosarcoma cells
Abstract Leptin, the product of the obese gene that plays an important role in the regulation of body weight that induces neuroprotection, neurogenesis, and angiogen...
Identification of the nasal mucosa as a new target for leptin action
Identification of the nasal mucosa as a new target for leptin action
Taildeman J, Demetter P, Rottiers I, Holtappels G, Bachert C, Cuvelier C A & Pérez‐Novo C A
(2010) Histopathology 56, 789–798
Identification of the nasal mucosa as a new target...
Hypothalamic Control of Bone Formation: Distinct Actions of Leptin and Y2 Receptor Pathways
Hypothalamic Control of Bone Formation: Distinct Actions of Leptin and Y2 Receptor Pathways
Abstract Leptin and Y2 receptors on hypothalamic NPY neurons mediate leptin effects on energy homeostasis; however, their interaction in modulating osteoblast activi...
Leptin Concentrations in Maternal and Umbilical Cord Blood in Relation to Maternal Weight, Birth Weight and Weight of the Placenta
Leptin Concentrations in Maternal and Umbilical Cord Blood in Relation to Maternal Weight, Birth Weight and Weight of the Placenta
Objective: Leptin is a hormone which regulates adipose tissue mass of the body. Substantial increase of leptin during pregnancy and detection of leptin and leptin receptor in place...
OR31-01 Hypothalamic glucose receptor - ADGRL1 - regulates leptin function in mice
OR31-01 Hypothalamic glucose receptor - ADGRL1 - regulates leptin function in mice
Abstract D.J. Samuel, DO: None. T.S. Faniyan: None. K.H. Chhabra: None. We recently identified Adgrl1 as a glucose receptor in the hypothalamus. Adgrl...

Back to Top